Skip to main content
Top
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Research

Hantaviruses and TNF-alpha act synergistically to induce ERK1/2 inactivation in Vero E6 cells

Authors: Tomas Strandin, Jussi Hepojoki, Hao Wang, Antti Vaheri, Hilkka Lankinen

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

Background

We have previously reported that the apathogenic Tula hantavirus induces apoptosis in Vero E6 epithelial cells. To assess the molecular mechanisms behind the induced apoptosis we studied the effects of hantavirus infection on cellular signaling pathways which promote cell survival. We previously also observed that the Tula virus-induced cell death process is augmented by external TNF-α. Since TNF-α is involved in the pathogenesis of hantavirus-caused hemorrhagic fever with renal syndrome (HFRS) we investigated its effects on HFRS-causing hantavirus-infected cells.

Results

We studied both apathogenic (Tula and Topografov) and pathogenic (Puumala and Seoul) hantaviruses for their ability to regulate cellular signaling pathways and observed a direct virus-mediated down-regulation of external signal-regulated kinases 1 and 2 (ERK1/2) survival pathway activity, which was dramatically enhanced by TNF-α. The fold of ERK1/2 inhibition correlated with viral replication efficiencies, which varied drastically between the hantaviruses studied.

Conclusion

We demonstrate that in the presence of a cytokine TNF-α, which is increased in HFRS patients, hantaviruses are capable of inactivating proteins that promote cell survival (ERK1/2). These results imply that hantavirus-infected epithelial cell barrier functions might be compromised in diseased individuals and could at least partially explain the mechanisms of renal dysfunction and the resulting proteinuria seen in HFRS patients.
Appendix
Available only for authorised users
Literature
2.
go back to reference Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, Vaheri A: Hantavirus infections in Europe. Lancet Infect Dis 2003, 3: 653-661. 10.1016/S1473-3099(03)00774-6CrossRefPubMed Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, Vaheri A: Hantavirus infections in Europe. Lancet Infect Dis 2003, 3: 653-661. 10.1016/S1473-3099(03)00774-6CrossRefPubMed
3.
go back to reference Plyusnin A, Vapalahti O, Vaheri A: Hantaviruses: genome structure, expression and evolution. J Gen Virol 1996, 77: 2677-2687. 10.1099/0022-1317-77-11-2677CrossRefPubMed Plyusnin A, Vapalahti O, Vaheri A: Hantaviruses: genome structure, expression and evolution. J Gen Virol 1996, 77: 2677-2687. 10.1099/0022-1317-77-11-2677CrossRefPubMed
4.
go back to reference Linderholm M, Ahlm C, Settergren B, Waage A, Tarnvik A: Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996, 173: 38-43.CrossRefPubMed Linderholm M, Ahlm C, Settergren B, Waage A, Tarnvik A: Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996, 173: 38-43.CrossRefPubMed
5.
go back to reference Liu JM, Zhu Y, Xu ZW, Quyang WM, Wang JP, Liu XS, Cao YX, Li Q, Fang L, Zhuang R, Yang AG, Jin BQ: Dynamic changes of apoptosis-inducing ligands and Th1/Th2 like subpopulations in Hantaan virus-induced hemorrhagic fever with renal syndrome. Clin Immunol 2006, 119: 245-251. 10.1016/j.clim.2006.02.010CrossRefPubMed Liu JM, Zhu Y, Xu ZW, Quyang WM, Wang JP, Liu XS, Cao YX, Li Q, Fang L, Zhuang R, Yang AG, Jin BQ: Dynamic changes of apoptosis-inducing ligands and Th1/Th2 like subpopulations in Hantaan virus-induced hemorrhagic fever with renal syndrome. Clin Immunol 2006, 119: 245-251. 10.1016/j.clim.2006.02.010CrossRefPubMed
6.
go back to reference Borges AA, Campos GM, Moreli ML, Souza RL, Aquino VH, Saggioro FP, Figueiredo LT: Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes Infect 2006, 8: 2324-2330. 10.1016/j.micinf.2006.04.019CrossRefPubMed Borges AA, Campos GM, Moreli ML, Souza RL, Aquino VH, Saggioro FP, Figueiredo LT: Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes Infect 2006, 8: 2324-2330. 10.1016/j.micinf.2006.04.019CrossRefPubMed
7.
go back to reference Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthöfer H: Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 1996, 78: 47-55. 10.1006/clin.1996.0007CrossRefPubMed Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthöfer H: Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 1996, 78: 47-55. 10.1006/clin.1996.0007CrossRefPubMed
8.
go back to reference Wimer BM: Implications of the analogy between recombinant cytokine toxicities and manifestations of hantavirus infections. Cancer Biother Radiopharm 1998, 13: 193-207.CrossRefPubMed Wimer BM: Implications of the analogy between recombinant cytokine toxicities and manifestations of hantavirus infections. Cancer Biother Radiopharm 1998, 13: 193-207.CrossRefPubMed
9.
go back to reference Mäkelä S, Hurme M, Ala-Houhala J, Mustonen J, Koivisto AM, Partanen J, Vapalahti O, Vaheri A, Pasternack A: Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection. Nephrol Dial Transplant 2001, 16: 1368-1373. 10.1093/ndt/16.7.1368CrossRefPubMed Mäkelä S, Hurme M, Ala-Houhala J, Mustonen J, Koivisto AM, Partanen J, Vapalahti O, Vaheri A, Pasternack A: Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection. Nephrol Dial Transplant 2001, 16: 1368-1373. 10.1093/ndt/16.7.1368CrossRefPubMed
10.
go back to reference Wajant H, Pfizenmaier K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ 2003, 10: 45-65. 10.1038/sj.cdd.4401189CrossRefPubMed Wajant H, Pfizenmaier K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ 2003, 10: 45-65. 10.1038/sj.cdd.4401189CrossRefPubMed
11.
go back to reference Li XD, Kukkonen S, Vapalahti O, Plyusnin A, Lankinen H, Vaheri A: Tula hantavirus infection in Vero E6 cells induces apoptosis involving caspase-8 activation. J Gen Virol 2004, 85: 3261-3268. 10.1099/vir.0.80243-0CrossRefPubMed Li XD, Kukkonen S, Vapalahti O, Plyusnin A, Lankinen H, Vaheri A: Tula hantavirus infection in Vero E6 cells induces apoptosis involving caspase-8 activation. J Gen Virol 2004, 85: 3261-3268. 10.1099/vir.0.80243-0CrossRefPubMed
12.
go back to reference Widmann C, Gibson S, Jarpe MB, Johnson GL: Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev 1999,79(1):143-180.PubMed Widmann C, Gibson S, Jarpe MB, Johnson GL: Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev 1999,79(1):143-180.PubMed
13.
go back to reference Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, McCubrey JA: Regulation of cell cycle progression and apoptosis by the RAS/RAF/MEK/ERK pathway (Review). Int J Oncol 2003,22(3):469-480.PubMed Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, McCubrey JA: Regulation of cell cycle progression and apoptosis by the RAS/RAF/MEK/ERK pathway (Review). Int J Oncol 2003,22(3):469-480.PubMed
14.
go back to reference Gardner AM, Johnson GL: Fibroblast growth factor-2 suppression of tumor necrosis factor-α mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 1996, 271: 14560-14566. 10.1074/jbc.271.24.14560CrossRefPubMed Gardner AM, Johnson GL: Fibroblast growth factor-2 suppression of tumor necrosis factor-α mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 1996, 271: 14560-14566. 10.1074/jbc.271.24.14560CrossRefPubMed
15.
go back to reference Grethe S, Pörn-Ares I: p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-α induced endothelial apoptosis. Cell Signal 2006, 18: 531-540. 10.1016/j.cellsig.2005.05.023CrossRefPubMed Grethe S, Pörn-Ares I: p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-α induced endothelial apoptosis. Cell Signal 2006, 18: 531-540. 10.1016/j.cellsig.2005.05.023CrossRefPubMed
16.
go back to reference Cai Y, Liu Y, Zhang X: Suppression of coronavirus replication by inhibition of the MEK signaling pathway. J Virol 2007, 81: 446-456. 10.1128/JVI.01705-06PubMedCentralCrossRefPubMed Cai Y, Liu Y, Zhang X: Suppression of coronavirus replication by inhibition of the MEK signaling pathway. J Virol 2007, 81: 446-456. 10.1128/JVI.01705-06PubMedCentralCrossRefPubMed
17.
go back to reference de Magalhaes JC, Andrade AA, Silva PNG, Sousa LP, Ropert C, Ferreira PCP, Kroon EG, Gazzineli T, Bonjardim CA: A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplicitation. J Biol Chem 2001, 276: 38353-38360. 10.1074/jbc.M100183200CrossRefPubMed de Magalhaes JC, Andrade AA, Silva PNG, Sousa LP, Ropert C, Ferreira PCP, Kroon EG, Gazzineli T, Bonjardim CA: A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplicitation. J Biol Chem 2001, 276: 38353-38360. 10.1074/jbc.M100183200CrossRefPubMed
18.
go back to reference Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S: Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol 2001, 3: 301-305. 10.1038/35060098CrossRefPubMed Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S: Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol 2001, 3: 301-305. 10.1038/35060098CrossRefPubMed
19.
go back to reference Schumann M, Dobbelstein M: Adenovirus-induced extracellular signal-regulated kinase phosphorylation during the late phase of infection enhances viral protein levels and virus progeny. Cancer Res 2006, 66: 1282-1288. 10.1158/0008-5472.CAN-05-1484CrossRefPubMed Schumann M, Dobbelstein M: Adenovirus-induced extracellular signal-regulated kinase phosphorylation during the late phase of infection enhances viral protein levels and virus progeny. Cancer Res 2006, 66: 1282-1288. 10.1158/0008-5472.CAN-05-1484CrossRefPubMed
20.
go back to reference Sharma-Walia N, Krishnan HH, Naranatt PP, Zeng L, Smith MS, Chandran B: ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J Virol 2005, 79: 10308-10329. 10.1128/JVI.79.16.10308-10329.2005PubMedCentralCrossRefPubMed Sharma-Walia N, Krishnan HH, Naranatt PP, Zeng L, Smith MS, Chandran B: ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J Virol 2005, 79: 10308-10329. 10.1128/JVI.79.16.10308-10329.2005PubMedCentralCrossRefPubMed
21.
go back to reference Wang J, Shen YH, Utama B, Wang J, LeMaire SA, Coselli JS, Vercellotti GM, Wang XL: HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis-involvement of ERK pathway. FEBS Lett 2006, 580: 2779-2787. 10.1016/j.febslet.2006.04.041CrossRefPubMed Wang J, Shen YH, Utama B, Wang J, LeMaire SA, Coselli JS, Vercellotti GM, Wang XL: HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis-involvement of ERK pathway. FEBS Lett 2006, 580: 2779-2787. 10.1016/j.febslet.2006.04.041CrossRefPubMed
22.
go back to reference Zampieri CA, Fortin JF, Nolan GP, Nabel GJ: The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. J Virol 2007, 81: 1230-1240. 10.1128/JVI.01586-06PubMedCentralCrossRefPubMed Zampieri CA, Fortin JF, Nolan GP, Nabel GJ: The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. J Virol 2007, 81: 1230-1240. 10.1128/JVI.01586-06PubMedCentralCrossRefPubMed
23.
go back to reference Macdonald A, Ka Yu Chan J, Harris M: Perturbation of epidermal growth factor receptor complex formation and Ras signalling in cells harbouring the hepatitis C virus subgenomic replicon. J Gen Virol 2005, 86: 1027-1033. 10.1099/vir.0.80724-0CrossRefPubMed Macdonald A, Ka Yu Chan J, Harris M: Perturbation of epidermal growth factor receptor complex formation and Ras signalling in cells harbouring the hepatitis C virus subgenomic replicon. J Gen Virol 2005, 86: 1027-1033. 10.1099/vir.0.80724-0CrossRefPubMed
24.
go back to reference Yoshizuka N, Yoshizuka-Chadani Y, Krishnan V, Zeichner SL: Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway. J Virol 2005, 79: 11366-11381. 10.1128/JVI.79.17.11366-11381.2005PubMedCentralCrossRefPubMed Yoshizuka N, Yoshizuka-Chadani Y, Krishnan V, Zeichner SL: Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway. J Virol 2005, 79: 11366-11381. 10.1128/JVI.79.17.11366-11381.2005PubMedCentralCrossRefPubMed
25.
go back to reference Kang JI, Park SH, Lee PW, Ahn BY: Apoptosis is induced by hantaviruses in cultured cells. Virology 1999, 264: 99-105. 10.1006/viro.1999.9896CrossRefPubMed Kang JI, Park SH, Lee PW, Ahn BY: Apoptosis is induced by hantaviruses in cultured cells. Virology 1999, 264: 99-105. 10.1006/viro.1999.9896CrossRefPubMed
26.
go back to reference Markotic A, Hensley L, Geisbert T, Spik K, Schmaljohn C: Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. J Gen Virol 2003, 84: 2197-2202. 10.1099/vir.0.19090-0CrossRefPubMed Markotic A, Hensley L, Geisbert T, Spik K, Schmaljohn C: Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. J Gen Virol 2003, 84: 2197-2202. 10.1099/vir.0.19090-0CrossRefPubMed
27.
go back to reference Masaki T, Foti R, Hill PA, Ikezumi Y, Atkins RC, Nikolic-Paterson DJ: Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int 2003, 63: 1256-1264. 10.1046/j.1523-1755.2003.00874.xCrossRefPubMed Masaki T, Foti R, Hill PA, Ikezumi Y, Atkins RC, Nikolic-Paterson DJ: Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int 2003, 63: 1256-1264. 10.1046/j.1523-1755.2003.00874.xCrossRefPubMed
28.
go back to reference Nagao S, Yamaguchi T, Kusaka M, Maser RL, Takahashi H, Cowley BD, Grantham JJ: Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. Kidney Int 2003, 63: 427-434. 10.1046/j.1523-1755.2003.00755.xCrossRefPubMed Nagao S, Yamaguchi T, Kusaka M, Maser RL, Takahashi H, Cowley BD, Grantham JJ: Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. Kidney Int 2003, 63: 427-434. 10.1046/j.1523-1755.2003.00755.xCrossRefPubMed
29.
go back to reference Kiely B, Feldman G, Ryan MP: Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance. Kidney Int 2003, 63: 908-916. 10.1046/j.1523-1755.2003.00804.xCrossRefPubMed Kiely B, Feldman G, Ryan MP: Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance. Kidney Int 2003, 63: 908-916. 10.1046/j.1523-1755.2003.00804.xCrossRefPubMed
30.
go back to reference Lipschutz JH, Li S, Arisco A, Balkovetz DF: Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J Biol Chem 2005, 280: 3780-3788. 10.1074/jbc.M408122200CrossRefPubMed Lipschutz JH, Li S, Arisco A, Balkovetz DF: Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J Biol Chem 2005, 280: 3780-3788. 10.1074/jbc.M408122200CrossRefPubMed
31.
go back to reference Li XD, Lankinen H, Putkuri N, Vapalahti O, Vaheri A: Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. Virology 2005, 333: 180-189. 10.1016/j.virol.2005.01.002CrossRefPubMed Li XD, Lankinen H, Putkuri N, Vapalahti O, Vaheri A: Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. Virology 2005, 333: 180-189. 10.1016/j.virol.2005.01.002CrossRefPubMed
32.
go back to reference Settergren B: Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: a review. Scand J Infect Dis 2000, 32: 125-132. 10.1080/003655400750045204CrossRefPubMed Settergren B: Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: a review. Scand J Infect Dis 2000, 32: 125-132. 10.1080/003655400750045204CrossRefPubMed
33.
go back to reference Kim S, Kang ET, Kim YG, Han JS, Lee JS, Kim YI, Hall WC, Dalrymple JM, Peters CJ: Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever. Am J Clin Pathol 1993, 100: 398-403.PubMed Kim S, Kang ET, Kim YG, Han JS, Lee JS, Kim YI, Hall WC, Dalrymple JM, Peters CJ: Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever. Am J Clin Pathol 1993, 100: 398-403.PubMed
34.
go back to reference Hautala T, Sironen T, Vapalahti O, Pääkkö E, Särkioja T, Salmela PI, Vaheri A, Plyusnin A, Kauma H: Hypophyseal hemorrhage and panhypopituitarism during Puumala virus infection: magnetic resonance imaging and detection of viral antigen in the hypophysis. Clin Infect Dis 2002, 35: 96-101. 10.1086/340859CrossRefPubMed Hautala T, Sironen T, Vapalahti O, Pääkkö E, Särkioja T, Salmela PI, Vaheri A, Plyusnin A, Kauma H: Hypophyseal hemorrhage and panhypopituitarism during Puumala virus infection: magnetic resonance imaging and detection of viral antigen in the hypophysis. Clin Infect Dis 2002, 35: 96-101. 10.1086/340859CrossRefPubMed
35.
go back to reference Klingström J, Hardestam J, Stoltz M, Zuber B, Lundkvist Å, Linder S, Ahlm C: Loss of cell membrane integrity in Puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J Virol 2006, 80: 8279-8282. 10.1128/JVI.00742-06PubMedCentralCrossRefPubMed Klingström J, Hardestam J, Stoltz M, Zuber B, Lundkvist Å, Linder S, Ahlm C: Loss of cell membrane integrity in Puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J Virol 2006, 80: 8279-8282. 10.1128/JVI.00742-06PubMedCentralCrossRefPubMed
36.
go back to reference Schmaljohn CS, Hasty SE, Dalrymple JM, LeDuc JW, Lee HW, von Bonsdorff CH, Brummer-Korvenkontio M, Vaheri A, Tsai TF, Regnery HL, Goldgaber D, Lee PW: Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 1985, 227: 1041-1044. 10.1126/science.2858126CrossRefPubMed Schmaljohn CS, Hasty SE, Dalrymple JM, LeDuc JW, Lee HW, von Bonsdorff CH, Brummer-Korvenkontio M, Vaheri A, Tsai TF, Regnery HL, Goldgaber D, Lee PW: Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 1985, 227: 1041-1044. 10.1126/science.2858126CrossRefPubMed
37.
go back to reference Vapalahti O, Lundkvist Å, Kukkonen SK, Cheng Y, Gilljam M, Kanerva M, Manni T, Pejcoch M, Niemimaa J, Kaikusalo A, Henttonen H, Vaheri A, Plyusnin A: Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J Gen Virol 1996, 77: 3063-3067. 10.1099/0022-1317-77-12-3063CrossRefPubMed Vapalahti O, Lundkvist Å, Kukkonen SK, Cheng Y, Gilljam M, Kanerva M, Manni T, Pejcoch M, Niemimaa J, Kaikusalo A, Henttonen H, Vaheri A, Plyusnin A: Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J Gen Virol 1996, 77: 3063-3067. 10.1099/0022-1317-77-12-3063CrossRefPubMed
38.
go back to reference Kallio ER, Klingström J, Gustafsson E, Manni T, Vaheri A, Henttonen H, Vapalahti O, Lundkvist Å: Prolonged survival of Puumala hantavirus outside the host: evidence of indirect transmission via the environment. J Gen Virol 2006, 87: 2127-2134. 10.1099/vir.0.81643-0CrossRefPubMed Kallio ER, Klingström J, Gustafsson E, Manni T, Vaheri A, Henttonen H, Vapalahti O, Lundkvist Å: Prolonged survival of Puumala hantavirus outside the host: evidence of indirect transmission via the environment. J Gen Virol 2006, 87: 2127-2134. 10.1099/vir.0.81643-0CrossRefPubMed
39.
go back to reference Vapalahti O, Kallio-Kokko H, Närvänen A, Julkunen I, Lundkvist A, Plyusnin A, Lehväslaiho H, Brummer-Korvenkontio M, Vaheri A, Lankinen H: Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J Med Virol 1995, 46: 293-303. 10.1002/jmv.1890460402CrossRefPubMed Vapalahti O, Kallio-Kokko H, Närvänen A, Julkunen I, Lundkvist A, Plyusnin A, Lehväslaiho H, Brummer-Korvenkontio M, Vaheri A, Lankinen H: Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J Med Virol 1995, 46: 293-303. 10.1002/jmv.1890460402CrossRefPubMed
Metadata
Title
Hantaviruses and TNF-alpha act synergistically to induce ERK1/2 inactivation in Vero E6 cells
Authors
Tomas Strandin
Jussi Hepojoki
Hao Wang
Antti Vaheri
Hilkka Lankinen
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-110

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.